The long range goals of this research are to contribute to the complete understanding of the pathogenesis and immunity of cholera at both the organismal and molecular levels. It is expected that this understanding will lead to the development of rational and effective methods of immunoprophylaxis as well as methods of pharmacologic intervention and treatment when the disease does occur. As cholera is the prototype of an expanding number of enterotoxic enteropathies, the observations will be pertinent to the larger global problem of secretory dirrheal disease. Our specific immediate concerns are to understand the mechanism(s) involved in the solid and lasting immunity which is produced following an attack of the disease itself, and the substantial immunity which is induced by the living attenuated A-B+ mutant Vibrio cholerae candidate vaccine strain, Texas Star-SR (produced by us, previously), as revealed in volunteer studies. It is our contention that the colonization factor(s) [adhesin(s)] of the cholera vibrios are equally as important as the enterotoxin in the pathogenesis, recovery from and immunology of cholera. Thus we propose to continue our studies on the nature and mechanism of action of the hemagglutinin/protease/""""""""cholera lectin"""""""", which we have described, as well as the other hemagglutinins (colonization factors?) produced by cholera vibrios. We wish to determine whether antibody to the colonization factor(s) plays a significant role in immunity. We also propose to study the similarities and differences in structure and antigenicity of cholera vibrios grown in vitro and in vivo. And we wish to define further the nature of the genetic lesion in the A gene of the Texas Star-SR mutant to determine whether deletions were produced so that the mutant may be predicted to be genetically, as well as operationally, stable.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Unknown (R22)
Project #
5R22AI017312-06
Application #
3444527
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1980-04-01
Project End
1986-06-30
Budget Start
1985-04-01
Budget End
1986-06-30
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Missouri-Columbia
Department
Type
Schools of Medicine
DUNS #
112205955
City
Columbia
State
MO
Country
United States
Zip Code
65211
Jouravleva, E A; McDonald, G A; Marsh, J W et al. (1998) The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139. Infect Immun 66:2535-9
Jouravleva, E A; McDonald, G A; Garon, C F et al. (1998) Characterization and possible functions of a new filamentous bacteriophage from Vibrio cholerae O139. Microbiology 144 ( Pt 2):315-24
Benitez, J A; Spelbrink, R G; Silva, A et al. (1997) Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in vitro colonization model. Infect Immun 65:3474-7
Finkelstein, R A; Boesman-Finkelstein, M; Sengupta, D K et al. (1997) Colonial opacity variations among the choleragenic vibrios. Microbiology 143 ( Pt 1):23-34
Robert, A; Silva, A; Benitez, J A et al. (1996) Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A. Vaccine 14:1517-22
Boesman-Finkelstein, M; Peterson, J W; Thai, L S et al. (1996) A nontoxic chimeric cholera toxin analog. Ann N Y Acad Sci 797:266-8
Boesman-Finkelstein, M; Peterson, J W; Thai, L S et al. (1996) A nontoxic cholera enterotoxin (CT) analog is chimeric with regard to both epitypes of CT-B subunits, CT-B-1 and CT-B-2. Infect Immun 64:346-8
Sengupta, D K; Boesman-Finkelstein, M; Finkelstein, R A (1996) Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge. Infect Immun 64:343-5
Hase, C C; Thai, L S; Boesman-Finkelstein, M et al. (1994) Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs. Infect Immun 62:3051-7
Hase, C C; Bauer, M E; Finkelstein, R A (1994) Genetic characterization of mannose-sensitive hemagglutinin (MSHA)-negative mutants of Vibrio cholerae derived by Tn5 mutagenesis. Gene 150:17-25

Showing the most recent 10 out of 37 publications